Cargando…

Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies

Dendritic cells (DCs) are the most potent professional antigen presenting cells and are therefore indispensable for the control of immunity. The technique of antibody mediated antigen targeting to DC subsets has been the basis of intense research for more than a decade. Many murine studies have util...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmann, Christian H. K., Heger, Lukas, Heidkamp, Gordon F., Baranska, Anna, Lühr, Jennifer J., Hoffmann, Alana, Dudziak, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931625/
https://www.ncbi.nlm.nih.gov/pubmed/27043640
http://dx.doi.org/10.3390/vaccines4020008
_version_ 1782440932282466304
author Lehmann, Christian H. K.
Heger, Lukas
Heidkamp, Gordon F.
Baranska, Anna
Lühr, Jennifer J.
Hoffmann, Alana
Dudziak, Diana
author_facet Lehmann, Christian H. K.
Heger, Lukas
Heidkamp, Gordon F.
Baranska, Anna
Lühr, Jennifer J.
Hoffmann, Alana
Dudziak, Diana
author_sort Lehmann, Christian H. K.
collection PubMed
description Dendritic cells (DCs) are the most potent professional antigen presenting cells and are therefore indispensable for the control of immunity. The technique of antibody mediated antigen targeting to DC subsets has been the basis of intense research for more than a decade. Many murine studies have utilized this approach of antigen delivery to various kinds of endocytic receptors of DCs both in vitro and in vivo. Today, it is widely accepted that different DC subsets are important for the induction of select immune responses. Nevertheless, many questions still remain to be answered, such as the actual influence of the targeted receptor on the initiation of the immune response to the delivered antigen. Further efforts to better understand the induction of antigen-specific immune responses will support the transfer of this knowledge into novel treatment strategies for human diseases. In this review, we will discuss the state-of-the-art aspects of the basic principles of antibody mediated antigen targeting approaches. A table will also provide a broad overview of the latest studies using antigen targeting including addressed DC subset, targeted receptors, outcome, and applied coupling techniques.
format Online
Article
Text
id pubmed-4931625
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49316252016-07-08 Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies Lehmann, Christian H. K. Heger, Lukas Heidkamp, Gordon F. Baranska, Anna Lühr, Jennifer J. Hoffmann, Alana Dudziak, Diana Vaccines (Basel) Review Dendritic cells (DCs) are the most potent professional antigen presenting cells and are therefore indispensable for the control of immunity. The technique of antibody mediated antigen targeting to DC subsets has been the basis of intense research for more than a decade. Many murine studies have utilized this approach of antigen delivery to various kinds of endocytic receptors of DCs both in vitro and in vivo. Today, it is widely accepted that different DC subsets are important for the induction of select immune responses. Nevertheless, many questions still remain to be answered, such as the actual influence of the targeted receptor on the initiation of the immune response to the delivered antigen. Further efforts to better understand the induction of antigen-specific immune responses will support the transfer of this knowledge into novel treatment strategies for human diseases. In this review, we will discuss the state-of-the-art aspects of the basic principles of antibody mediated antigen targeting approaches. A table will also provide a broad overview of the latest studies using antigen targeting including addressed DC subset, targeted receptors, outcome, and applied coupling techniques. MDPI 2016-03-28 /pmc/articles/PMC4931625/ /pubmed/27043640 http://dx.doi.org/10.3390/vaccines4020008 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lehmann, Christian H. K.
Heger, Lukas
Heidkamp, Gordon F.
Baranska, Anna
Lühr, Jennifer J.
Hoffmann, Alana
Dudziak, Diana
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
title Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
title_full Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
title_fullStr Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
title_full_unstemmed Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
title_short Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
title_sort direct delivery of antigens to dendritic cells via antibodies specific for endocytic receptors as a promising strategy for future therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931625/
https://www.ncbi.nlm.nih.gov/pubmed/27043640
http://dx.doi.org/10.3390/vaccines4020008
work_keys_str_mv AT lehmannchristianhk directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies
AT hegerlukas directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies
AT heidkampgordonf directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies
AT baranskaanna directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies
AT luhrjenniferj directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies
AT hoffmannalana directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies
AT dudziakdiana directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies